Conjugation of siRNA with Comb-Type PEG Enhances Serum Stability and Gene Silencing Efficiency

被引:41
作者
Gunasekaran, Karthikeyan [1 ]
Nguyen, Thi H. [2 ]
Maynard, Heather D. [2 ]
Davis, Thomas P. [3 ]
Bulmus, Volga [1 ,4 ]
机构
[1] Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, Sydney, NSW 2052, Australia
[2] Univ Calif Los Angeles, Dept Chem & Biochem, Calif NanoSyst Inst, Los Angeles, CA 90095 USA
[3] Univ New S Wales, Sch Chem Sci & Engn, Australian Ctr Nanomed, Sydney, NSW 2052, Australia
[4] Izmir Inst Technol, Dept Chem Engn, TR-35430 Izmir, Turkey
基金
澳大利亚研究理事会;
关键词
biological applications of polymers; PEG(meth)acrylate; polymer conjugates; reversible addition fragmentation chain transfer polymerization (RAFT); siRNA; POLYELECTROLYTE COMPLEX MICELLES; POLY(ETHYLENE GLYCOL)-SIRNA CONJUGATE; LIVING RADICAL POLYMERIZATION; VEGF SIRNA; REVERSIBLE ADDITION; DELIVERY; PEGYLATION; POLYMERS; PEPTIDE; DESIGN;
D O I
10.1002/marc.201000804
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
A thiol-modified siRNA targeting the enhanced green fluorescence protein (eGFP) gene was conjugated with RAFT-synthesized, pyridyl disulfide-functional poly(PEG methyl ether acrylate) s (p(PEGA) s). siRNA-p(PEGA) conjugates demonstrated significantly enhanced in vitro serum stability and nuclease resistance compared to the unmodified and thiol-modified siRNA. The complexes of siRNA-p(PEGA) conjugates with a fusogenic peptide, KALA ((+)/(-) = 2) inhibited the protein expression approximately 28-fold more than the KALA complex of the unmodified siRNA. The protein inhibition caused by siRNA-p(PEGA)-KALA complexes (56 +/- 5%-58 +/- 3% of the fluorescence expressed in non-treated cells) was comparable to the effect of the unmodified siRNA-lipofectamine complex (77 +/- 7%).
引用
收藏
页码:654 / 659
页数:6
相关论文
共 34 条
[31]   Elucidating brain transport pathways and cell type-dependent gene silencing of a durable lipid-siRNA conjugate administered into cerebrospinal fluid [J].
Sorets, Alexander G. ;
Schwensen, Katrina R. ;
Francini, Nora ;
Kjar, Andrew ;
Abdulrahman, Adam M. ;
Shostak, Alena ;
Katdare, Ketaki A. ;
Schoch, Kathleen M. ;
Cowell, Rebecca P. ;
Park, Joshua C. ;
Ligocki, Alexander P. ;
Ford, William T. ;
Ventura-Antunes, Lissa ;
Hoogenboezem, Ella N. ;
Prusky, Alex ;
Castleberry, Mark ;
Michell, Danielle L. ;
Fritsch, Emma ;
Lyons, Sarah M. ;
Miller, Timothy M. ;
Vickers, Kasey C. ;
Schrag, Matthew S. ;
Duvall, Craig L. ;
Lippmann, Ethan S. .
NUCLEIC ACIDS RESEARCH, 2025, 53 (12)
[32]   Silencing of the scavenger receptor (Class B - Type 1) gene using siRNA-loaded chitosan nanaoparticles in a HepG2 cell model [J].
Farid, Mariane M. ;
Hathout, Rania M. ;
Fawzy, Mahmoud ;
Abou-Aisha, Khaled .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2014, 123 :930-937
[33]   Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer [J].
Rochester, MA ;
Riedemann, J ;
Hellawell, GO ;
Brewster, SF ;
Macaulay, VM .
CANCER GENE THERAPY, 2005, 12 (01) :90-100
[34]   Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer [J].
Mark A Rochester ;
Johann Riedemann ;
Giles O Hellawell ;
Simon F Brewster ;
Valentine M Macaulay .
Cancer Gene Therapy, 2005, 12 :90-100